PNC FINANCIAL SERVICES GROUP, INC. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$0
-100.0%
5
-99.6%
0.00%
Q2 2022$44,000
-33.3%
1,410
-26.9%
0.00%
Q1 2022$66,000
-42.1%
1,928
-50.7%
0.00%
Q4 2021$114,000
+2.7%
3,913
-10.3%
0.00%
Q3 2021$111,000
-15.3%
4,360
+17.1%
0.00%
Q2 2021$131,000
-22.9%
3,722
-10.9%
0.00%
Q1 2021$170,000
-7.1%
4,176
-1.1%
0.00%
Q4 2020$183,000
-49.4%
4,222
-35.6%
0.00%
Q3 2020$362,000
-12.6%
6,552
-0.3%
0.00%
-100.0%
Q2 2020$414,000
+38.0%
6,575
+11.8%
0.00%
Q1 2020$300,000
-13.3%
5,882
+35.2%
0.00%
Q4 2019$346,000
+48.5%
4,352
-9.4%
0.00%
Q3 2019$233,000
+1.7%
4,806
+10.4%
0.00%
Q2 2019$229,000
-0.4%
4,3520.0%0.00%
Q1 2019$230,000
+28.5%
4,3520.0%0.00%
Q4 2018$179,000
+8.5%
4,352
-0.0%
0.00%
Q3 2018$165,000
+617.4%
4,353
+740.3%
0.00%
Q2 2018$23,000
+53.3%
518
+63.9%
0.00%
Q1 2018$15,000
+1400.0%
316
+1115.4%
0.00%
Q4 2017$1,000260.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2019
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders